Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PUBLIC FLOAT 21.5M! Low Floater! MARKET CAP $97.62K
SHARES OUTSTANDING 35.5M
https://www.marketwatch.com/investing/stock/nuvi
$NUVI 21.5M float! Also very low floater here. pic.twitter.com/fmkU4x2EMQ
— DazeTrader (@DazeTrader) February 7, 2019
Maybe a new buyer has cleared their debt?
$AVRN on 12/08/2018 market change from Pink No Information to Pink Current. New 10-K just filed now on SEC Edgar: http://bit.ly/2UkFXge #blockchain #cryptocurrency $GBTC @i_like_bb_stock new run starts now.
Yes I agree. The payment for order flow bots have entered the OTC Markets. Do you know what I'm talking about?
"We strive to become a leader in immuno-therapeutic treatment and prevention of HIV/AIDS, Cancer and other immuno related disorders."
Our flagship compound ITV-1, which studies have shown is effective in the treatment of HIV/AIDS and Hepatitis C viruses and to modulate the immune system.
Check company's website http://www.enzolytics.com/ there is lots of very interesting info. $ENZC
one for 1,400 reverse split. Why do companies do such massive reverse splits?
Lucky, which broker filled your order? I also had GTC bids down here but didn't get any shares.
Wow awesome! Thanks for the enlightenment.
Sorry, what do you mean?
I have not seen any dilution! :)
GNGR's corporate structure as of August 22, 2018 is:
- 108,553,765 shares in the float.
- Is profitable.
- Maintains a low overhead that is under 1% of the "NET PROFITS" (unheard of in any business)
- No financing needed as all orders are prepaid at retail level through websites and internet sales.
- Never been a shell company.
- No reverse stock splits.
- Never reverse merged.
- No ticker symbol change.
- No dilution
- No convertible debt or funding notes
Source: http://www.gugr.com/gngr-update.html
Gunther Grant, Inc. (GNGR) Has taken all of the elements that are the cause of business failures and eliminated them.
GNGR has created a corporate structure that guarantees GNGR can not fail under normal business procedures. Even many fortune 500 companies cannot duplicate this structure. Many corporations make small profits but at tremendous labor and overhead while GNGR's structure has all but eliminated operating, overhead and material costs while maintaining higher profit margins that exceed some of the nations TOP corporations including Apple, Berkshire Hathaway, Amazon and many of the fortune 500 companies.
When corporations fall on hard times, the first thing they do is lay off people to increase the bottom line. Labor is such a large cost factor for most businesses, but not for GNGR. Our labor costs and overhead combined are under 1% of the net. GNGR has almost no overhead to worry about and no, high cost labor issues.
-
We could not post this if it were not true AND we can prove it! Our operating and overhead costs come to less than 1% of the net profits, and the materials (sterling silver and gold) GNGR uses in castings costs GNGR below true market values allowing GNGR to sell close to or "AT" actual silver and gold market values and still make a very significant net profit that all of our competitors are unable to do including Tiffany & Co., Signet (Jared, Kay jewelers), and all major retailers and even China's Jewelry industry. If the world market price of Sterling Silver is $15.00 per ounce, GNGR can sell jewelry castings at $15.00 "or less" per ounce and still net a higher profit then most if not all fortune 500 companies.
-
How can GNGR cast and sell solid .925 sterling silver at actual or lower than silver market prices and make significant net profits at percentage levels that NO OTHER jewelry or any company we know of can match? That is one of our trade secrets.
Fake silver marked jewlery is a REAL threat. (click here)
-
Also this data about FAKE jewelry marked .925 and STERLING from:
The Society of American Silversmiths. (click here)
-
ALL GNGR CASTINGS ARE MADE IN THE USA and we used ONLY the highest grade USA sourced .925 and .999 pure silver. And .999 pure 22k gold that we reduce to 14k and 18k by adding silver copper or argnetium to make various colored gold tones by request (see our SKULLS for shades of gold on our PRODUCT$ page)
-
Our goal now is to continue to expand on that structure that has already provided worldwide sales and deliveries while keeping our costs under strict control so that GNGR cannot fail and always remains profitable. Many of our buyers are very skeptical at our prices and many actually took our purchased castings to jewelry stores to have them tested. All confirmed GNGR is using only pure .925 sterling silver in all our castings. Our feedback speaks for itself and or expansion worldwide is NOT going to slow down. To review feedback (click here)
-
Our costs are under such control, if we don't even take in one order, GNGR has hardly any expenses to cover. GNGR only incurs some additional minimal costs "after" orders are placed. And since orders are pre paid, GNGR also does not need any production financing or factoring receivables because we have no receivables.
-
GNGR had filed to be OTC current, with up to date financial's that were better than most (possibly all) OTC companies listed. GNGR posted the low float share structure and positive revenue. That coupled with proven continued sales, and new items being added to our line and a fantastic PR Newswire sent to the investment community has proven GNGR is a stable growing company. GNGR continues to expand and increase the reach to more buyers all over the globe.
UPDATE:
More updates coming soon.
LEGAL DISCLAIMER - Copyright 2018 Gunther Grant, Inc
Positive NEWS from $IVOB today!
https://www.prnewswire.com/news-releases/invo-bioscience-announces-two-poster-presentations-at-the-2018-american-society-for-reproductive-medicine-asrm-congress--expo-300733382.html
INVO Bioscience Announces Two Poster Presentations at the 2018 American Society for Reproductive Medicine (ASRM) Congress & Expo
Among the findings, after 3 dIUI cycles, an Intravaginal culture (INVOcell) cycle appears to be a more cost-effective option for lesbian couples. $IVOB
Intravaginal culture (INVOcell) offers a significant increase in pregnancy rates compared with intrauterine insemination (IUI).
INVO Bioscience (IVOB) is a medical device company, headquartered in Medford, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. The company's lead product, the INVOcell, is a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity.
NEWS PROVIDED BY
INVO Bioscience, Inc.
08:31 ET
SHARE THIS ARTICLE
MEDFORD, Mass., Oct. 18, 2018 /PRNewswire/ -- INVO Bioscience, Inc. (OTC: IVOB), a medical device company who was granted FDA clearance for the first Intravaginal Culture System, today announced that two posters were presented at the 74th Scientific Congress & Expo of the American Society for Reproductive Medicine (ASRM) this past week in Denver, Colorado.
"ASRM was once again an incredible event for INVO Bioscience and our INVOcell device and procedure," commented Katie Karloff, CEO of INVO Bioscience. "INVOcell was highlighted in two poster presentations outlining the cost benefits of INVOcell's intravaginal culture system. The first, presented by Julia Butler, evaluated whether intravaginal culture is a more economical treatment for lesbian couples. The study found that when considering the all-in cost of treatment, that after 3 dIUI cycles (donor sperm with intrauterine insemination), an INVOcell cycle appears to be a more cost-effective option for lesbian couples. The second, presented by Ryan Miller, is a retrospective study aimed to assess the efficacy of the INVOcell intravaginal culture device with fresh transfers compared with intrauterine insemination (IUI) cycles at the Piedmont Reproductive Endocrinology Group, or PREG, where both are Clinical Embryologists and Lab Managers. The study concluded that the INVOcell intravaginal culture offers a significant increase in pregnancy rates compared with IUI and offers a novel treatment that gives patients an option between a simple IUI and a full IVF cycle. These studies affirm our mission to expand fertility treatment across the globe with a goal to lower the cost and increase availability of care."
Details of the poster presentations can be found on the INVO Bioscience website at https://invobioscience.com/resources/.
Is intravaginal culture a more economical treatment for lesbian couples?
J. Butler MS, M. Darmer BS, J. Payne MD, T. McCoy MD, E. Tarnawa MD
Piedmont Reproductive Endocrinology Group, Greenville, SC
Intravaginal embryo culture: More than just a novelty?
Ryan Miller, Travis McCoy, Edward Tarnawa, John Payne
Piedmont Reproductive Endocrinology Group, Greenville, SC
Clemson University, Clemson, SC
Additional highlights from ASRM
INVO Bioscience hosted several strategic meetings with industry leaders both from within the United States as well as internationally and assembled a KOL gathering of 30 current INVOcell adopters to discuss an array of topics, including the latest advancements in clinical management and research, and shared ideas on best practices for the INVOcell device.
INVO Bioscience's booth and participation added a critical addition to Scientific Congress & Expo by educating attendees on the novel device and procedure that provides a more natural, safe, effective and economical fertility treatment. This engagement lead to INVO Bioscience making over 200 key new contacts during the duration of the event.
Ms. Karloff concluded, "I couldn't be more pleased with the reception that we received at this year's event. It is gratifying to meet with many of our existing physicians that are utilizing INVOcell and are achieving tremendous results. Likewise, it was exciting to share the opportunity that INVOcell provides to potential new users that are looking for ways to bridge the treatment gap between providing an effective solution that can be accessible for an expanding patient population and decreased cost of care."
About INVOcell
The INVOcell device and procedure is a disruptive new technology and a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience. With INVO Bioscience's mission to increase access to care and expand fertility treatment and patient care across the globe, they were a perfect addition for ASRM.
INVOcell™ key features & benefits:
Provides a more natural incubation environment.
Offers an affordable treatment, which may reduce the risk of wrong embryo transfers.
Uses mild stimulation, which may reduce the risk of ovarian hyper-stimulation.
Increases geographic accessibility (and access to care) to more patients with equivalent safety and efficacy compared to traditional IVF.
Provides psychological benefits and promotes increased involvement by couples.
Simpler procedure - decreases overall costs to physician and decreases patients costs by ~ 50% compared to IVF procedure rates.
Cost per actual pregnancy may be less than multiple IUI attempts.
About INVO Bioscience
We are a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Our solution, the INVO Procedure, is a disruptive new technology. The INVO Procedure is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience. Our lead product, the INVOcell, is a patented medical device used in infertility treatment and is considered an Assisted Reproductive Technology (ART). The INVOcell is the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development, as an alternative to traditional In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI). Our mission is to increase access to care and expand fertility treatment across the globe with a goal to lower the cost of care and increase availability of care. For more information, please visit http://invobioscience.com/.
Safe Harbor Statement
This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company invokes the protections of the Private Securities Litigation Reform Act of 1995. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategies, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in our filings at www.sec.gov. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Company Contact:
Kathleen Karloff, CEO
INVO Bioscience, Inc.
978-878-9505 ext. 504
kkarloff@invobio.com
SOURCE INVO Bioscience, Inc.
Related Links
http://invobioscience.com/
Also from this source
14 AUG, 2018, 16:05 ET
INVO Bioscience Reports Record Second Quarter 2018 Financial...
Explore
More news releases in similar topics
All Summer Health & Safety News Releases
Health
Medical Pharmaceuticals
General Business
People & Culture
You just read:
INVO Bioscience Announces Two Poster Presentations at the 2018 American Society for Reproductive Medicine (ASRM) Congress & Expo
NEWS PROVIDED BY
INVO Bioscience, Inc.
08:31 ET
https://www.prnewswire.com/news-releases/invo-bioscience-announces-two-poster-presentations-at-the-2018-american-society-for-reproductive-medicine-asrm-congress--expo-300733382.html
Contact PR Newswire
888-776-0942
from 8 AM - 10 PM ET
Chat Online with an Expert
Contact Us
$IVOB
Do you know the date of which they updated their company profile to include the piece about cannabis?
I doubt people have heard this yet.
Hi, I've noticed a number of tickers you trade have their headquarters in China or Asia. What do you like about these types of stocks, what draws you to them? Is it cuz of a particular style of trading (wide spreads) that you like? Or the potential market caps and the potential to expand greatly due to the large population size? Thanks.
Very_tight_Share_Structure $TAMO oil & gas corp. I like this share structure because the outstanding share amount of 746M is right near the authorized share amount of 750M. And as per their most recent financial statements (10Q and 10K) the company doesn't have convertibles, promissory notes, etc. No dilutive financing. In other words, no dilution and float probably locked. @DJPennyTrader @ShortSqueezed1
TAMO SECURITY DETAILS
Share Structure
Market Cap 1,045,216 10/09/2018
Authorized Shares 750,000,000 09/28/2018
Outstanding Shares 746,582,585 09/28/2018
Restricted 703,328,714 09/28/2018
Unrestricted 43,253,871 09/28/2018
Held at DTC 36,095,506 09/28/2018
Float Not Available
https://www.otcmarkets.com/stock/tamo/security
Ready for power hour, L2 very thin offers!
Introducing KonaRed's NEW Nakoa Blend!
Not Your Average Kona Blend.
Nakoa, meaning brave warrior, strength and spirit in the Hawaiian language.
At KonaRed®, we take pride in where we have been, where we are, and where we are going. With the spirit of the Hawaiian Islands and its warriors in every cup, we proudly introduce our newest blend, The Nakoa "Warrior" Blend.
Our NEW Nakoa Blend Coffee is made with our historical Greenwell Farms Kona coffee beans, blended with carefully selected Latin and Indonesian coffee beans that delivers a balanced full-bodied and sweet flavor with notes of Chocolate, Fruit, Maple and Cedar.
More than excited, we are proud to offer a specialty quality blend and a robust flavor profile fit for the warrior in all of us!
Much like the Hawaiian farmers who put their time and care into cultivating the coffee plant, we do the same in roasting every batch. All of our coffee is small batch roasted in-house, making it a true labor of love, from seed to cup.
So, this is for you. Grab a cup, take a sip, and embrace not just the Hawaiian islands but your own Nakoa Spirit.
https://www.konared.com/
https://www.konared.com/blogs/news
DD. Review $IMUN most read articles here:
https://www.immunetherapeutics.com/2018/03/immune_therapeutics_inc_received_minutes_from_fda_meeting_for_lodonal_for_the_treatment_for_crohns_disease/
https://www.immunetherapeutics.com/2017/09/immune-therapeutics-inc-announces-exclusive-agreement-for-sale-of-lodonal-in-kenya-valued-at-over-31-million/
https://www.immunetherapeutics.com/2017/11/immune-therapeutics-inc-shareholder-update-letter/
https://www.immunetherapeutics.com/project/lodonal-kenya/
https://www.immunetherapeutics.com/project/china-car-t/
https://www.immunetherapeutics.com/project/malawi-medical-equipment-donation/
Alas, but how do we fight dilution?
Hey, just trying to understand why would the 2016 milly buyer need to dump first before the stock price can rise?
Did_not_think_I'd_get_an opportunity to load cheapies again.
Remember the short squeeze from $0.01_to_0.03 last time?
Any updates on news of Fidson revenues beginning?
I agree. People don't care to hold very long anymore.
82.2k shares sold short as of 06/29/2018, that trader gonna get squeezed today :)
https://www.otcmarkets.com/stock/inno/security
OTCMarkets.com indicates float is 33.3M with O/S at 152M at Auth Shares at 199M. Very nice share structure!
https://www.otcmarkets.com/stock/inno/security
level2 very thin on the ask! $0.015 is on deck and the party hasn't even started yet!
daily and weekly charts primed for a breakout in combination with today's 8-K.
8-K SEC Filing last night! details enclosed here.
$INNO
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 25, 2018
INNOCAP, INC.
(Exact name of registrant as specified in its charter)
Nevada
333-153035
01–0721929
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification Number)
112 N. Walnut Street
PO Box 489
Jefferson, TX 75657-0489
(Address of principal executive offices) (zip code)
770-378-4180
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General InstructionA.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 OTHER EVENTS.
In November 2017, Innocap entered into an agreement with Solar Resources Inc. (“Solar”), a company in Singapore, to assist Solar to recover large shipments of tin from two sunken ships that are believed to be in the waters between Singapore, the Philippines, Indonesia and Malaysia.
The salvage ship has been in the waters near the Philippines searching the area where one of the sunken ships is believed to be when its Dynamic Positioning (DP) system, a computer-controlled system that automatically maintains a vessel's position and heading, began to malfunction. The vessel has returned to harbor in Singapore for repairs and will continue the salvage project as soon as repairs are complete.
No assurances can be given that the sunken ship will be found or that its contents will be consistent with reports describing such contents.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, Innocap, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: September 25, 2018
/s/ Paul Tidwell
Paul Tidwell
Chief Executive Officer
https://www.otcmarkets.com/filing/html?id=12977155&guid=JnLZUapHzDimZth
Small float 7.56M as-of 09-14-2018, OTCQB-Certification 09/18/2018
https://backend.otcmarkets.com/otcapi/company/financial-report/202750/content
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143682358
OTCQB Certification $NRIS 09/18/2018
https://backend.otcmarkets.com/otcapi/company/financial-report/202750/content
I, Patrick Norris, [CEO] of [Norris Industries, Inc.] (“the Company”), certify that:
a. The Company is registered or required to file periodic reporting with the SEC or is exempt from SEC
registration as indicated below (mark the box below that applies with an “X”):
[X] Company is registered under Section 12(g) of the Exchange Act
[ ] Company is relying on Exchange Act Rule 12g3-2(b)
[ ] Company is a bank that reports to a Bank Regulator under Section 12(i) of the Exchange Act
[ ] Company is a bank that is non-SEC reporting but is current in its reporting to a Banking Regulator
[ ] Company is reporting under Section 15(d) of the Exchange Act.
[ ] Company is reporting under the Alternative Reporting Company Disclosure Guidelines
[ ] Other (describe)
b. The Company is current in its reporting obligations as of the most recent fiscal year end and any subsequent
quarters, and such information has been posted either on the SEC’s EDGAR system or the OTC Disclosure &
News Service, as applicable.
c. The Company Profile displayed on www.otcmarkets.com is current and complete as of Sept 14, 2018 and
includes the total shares outstanding, authorized, and in the public float as of that date.
d. Please provide the following information as of the latest practicable date:
i. Number of Beneficial Owners holding at least 100 shares: 120 as of September 14, 2018
(“Beneficial Owner” shall mean any person who, directly or indirectly has or shares voting power of such
security or investment power, which includes the power to dispose, or to direct the disposition of, such
security.)
ii. Number of shares in the Public Float: 7,561,864 as of September 14, 2018
(“Public Float” shall mean the total number of unrestricted shares not held directly or indirectly by an officer,
director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding, or
any Affiliates thereof, or any Immediate Family Members of officers, directors and control persons.)
e. The company is duly organized, validly existing and in good standing under the laws of Nevada in which the
Company is organized or does business.
f. Identify any law firm and attorney(s) that acted as the Company’s primary legal counsel in preparing its most
recent annual report. Include the firm and attorney(s) name if outside counsel, or name and title if internal counsel.
(If no attorney assisted in putting together the disclosure, the Company must identify the person or persons who
prepared the disclosure and their relationship to the company.) Please also identify any other attorney, if different
than the primary legal counsel, that assisted the company during the prior fiscal year on any matter including but
not limited to, preparation of disclosure, press releases, consulting services, corporate action or merger assistance,
etc.
GOLENBOCK, EISEMAN ASSOR BELL & PESKOE LLP in NY- Mr. Andrew Hudders, Esq.
g. The following is a complete list of third party providers, including names and addresses, engaged by the
Company, its officers, directors or controlling shareholders, during the period from the Company’s prior fiscal year
end to the date of this OTCQB Certification, to provide investor relations services, public relations services,
marketing, brand awareness, consulting, stock promotion, or any other related services to the Company.
None currently: Company ceased all prior outside stock promotions, consulting, and promoters in August 2017
OTC Markets Group Inc. March 14, 2018
h. The following is a complete list of Officers, Directors and Control Persons (control persons are beneficial owners
of more than five percent (5%) of any class of the issuer’s equity securities), including name, address, and number
of shares owned. Options and warrants that can be converted into common shares within the next 60 days should
be included in the shareholdings listed below. If any of the beneficial shareholders are corporate entities, provide
the name and address of the person(s) owning or controlling such corporate entities.
Name Address (City and State only) Number of Shares Owned
Mr.Patrick Norris, Chairman,
CEO and related entity JBB
3011 W. Admiral Doyle
New Iberia, LA 70560
51,500,000 common shares,
plus 1,000,000 Preferred shares,
or Aproximately 57.55% of total
issued, and outstanding common
shares, and 100% of Preferred
Ross Ramsey, Director/E&P
Division Officer
154 Oakwood Creek Lane
Weatherford, TX 76088
2,000,000 common shares, or
Aproximately 2.24% of total
issued and outstanding shares
Patrick L. Riggs, and related
entity Riggs Capital, Inc. Per 13D
filing made in August 2017
10530 Normont Drive
Houston, TX 77070
5,900,000 common shares, or
Aproximately 6.61% of total
issued and outstanding shares
Date: September 17, 2018
Name of Certifying CEO or CFO: Patrick Norris
Title: CEO
Signature: */s/ Patrick Norris
(Digital Signatures should appear as “/s/ [OFFICER NAME]”)
LIFE CHANGING NEWS for $QWTR TODAY!
QUEST WATER PROVIDES CORPORATE UPDATE
September 20, 2018 - 9:10 AM EDT
VANCOUVER, CANADA, Sept. 20, 2018 (GLOBE NEWSWIRE) -- QUEST WATER GLOBAL, INC. (OTC Pink: QWTR) ("Quest" and/or the "Company"), an innovative water technology company and developer of the solar-powered AQUAtap™ water purification, desalination, and distribution technology and WEPS™ WaterMaker Atmospheric Water Extraction and Purification System, announced today an update on current business activities and ongoing operations.
Financial Reporting Requirements and Continuous Disclosure Obligations
On April 23, 2015, the British Columbia Securities Commission (the “BCSC”) issued a cease trade order (the “CTO”) against the Company that applies to investors in Canada. On October 12, 2016, the Company obtained a partial revocation of the CTO in order to complete a private placement financing, raising sufficient funds to prepare and file all of its outstanding disclosure documents including quarterly and annual reports. Although it has taken longer than expected to complete the financing, the Company continues to work diligently towards achieving compliance with its financial reporting requirements and continuous disclosure obligations in both the U.S. and Canada, which will eventually allow the Company to obtain a full revocation of the CTO.
Cape Town, South Africa
The City of Cape Town is currently experiencing its worst drought since 1904. In order to ease the pressure placed on the water supply, municipalities across the Western Cape continue to implement water restrictions. These restrictions heavily impact commercial and industrial users who are required to reduce their water use by 45%. The failure to comply constitutes an offence under the City’s water by-laws.
In response to this, Quest has partnered with a Cape Town organization to market the Company’s products to commercial, industrial, and institutional customers throughout the Western Cape. Together with its partner, the Company recently submitted several proposals allowing businesses to become water independent by installing and implementing various configurations of the Company’s cost-effective AQUAtap™ system utilizing ground water and seawater sources.
Additionally, the Company recently shipped a WEPS™ WaterMaker Atmospheric Water Extraction & Purification system to Cape Town for demonstration purposes. The Company and its partner intend to launch a marketing campaign of the WEPS™ WaterMaker product within the Western Cape, including a website committed solely to this product.
Colombia, Ecuador, Panama and Cuba
Quest recently appointed a new distributor in Colombia to market and sell the Company’s full line of products. The distributor was granted exclusivity in Colombia based on a pre-paid initial order and on a non-exclusive basis in Ecuador, Panama, and Cuba. The initial order of WEPS™ WaterMaker systems has shipped and is expected arrive in Bogota in October 2018. The distributor is developing several sales opportunities, especially within the vicinity of the Caribbean coast of Colombia.
Republic of Haiti
Further to the Company’s press release dated September 8, 2016, Quest is making significant progress with its Build-Own-Operate Business Model. Together with its Haitian partner, the Company is in the process of completing the registration of a new joint venture company in the Caribbean nation. This company plans to supply, install and operate 50 AQUAtap™ systems for the provision and vending of purified drinking water in rural communities within Haiti. Quest’s executives met with and submitted a comprehensive proposal to the Government of Haiti in February 2018 for the formation a Public-Private Partnership (“PPP”) which will assist in the execution of this undertaking. The Company is now negotiating the terms of the PPP to supply clean water to 200,000 people within marginalized rural communities.
In addition, the Company recently shipped a WEPS™ WaterMaker Atmospheric Water Extraction & Purification systems to Haiti for demonstration purposes.
Democratic Republic of Congo
The Company recently received an opportunity to sell AQUAtap™ water purification & distribution systems into the Democratic Republic of Congo in partnership with a large corporation in the capital city of Kinshasa. Quest, together with its proposed partner, is working on the initial pilot project which proposes the installation of one, 80,000 liter per day freshwater AQUAtap™ within a rural community close to the capital city. Once the pilot project is deemed a success, this opportunity has the potential to see further AQUAtap™ installations throughout the country.
Republic of Ghana
The Company, together with its local partner in Accra, are in the submission stage of a proposal to the Government of the Republic of Ghana through The Water Resources Commission and the Ghana Water Company (formerly Ghana Water and Sanitation Corporation) to supply, install, and operate 50 AQUAtap™ systems for the provision and vending of purified drinking water within rural communities of the country.
Canadian First Nations
The Company is working closely with Chief Gibby Jacob & Associates (CGJA) to introduce Quest’s entire line of products to First Nations communities across Canada, representing more than 1.3 million indigenous people. CGJA currently works with corporations and First Nations offering solutions for positive change. These solutions are necessary to build First Nations communities capable of thriving into future generations. CGJA recently launched their corporate website, www.chiefgibbyjacob.com, which will be utilized to promote their partner’s technologies including those of the Company. Quest Water and CGJA are working towards finalizing a partnership agreement which will strengthen their mutual interests.
Advisory Board
Further to the Company’s press release dated September 29, 2016, Quest continues to strengthen its Advisory Board. The Company now features a 6-person Advisory Board that spans many segments of business, indigenous affairs, and the water industry. The newest addition and contributor to the Board is Skwxwú7mesh Úxwumixw (Squamish Nation) hereditary Chief Gilbert ‘Gibby’ Jacob. Chief Jacob is one of the most influential First Nations leaders in Canada and was twice recognized as a significant member of society receiving both the Queens Diamond Jubilee Medal in 2012 and the Senate 150 Anniversary Medal in 2018.
Chief Gibby Jacob helped broker the deal that established the Squamish Lil'wat Cultural Centre in Whistler, British Columbia as well as the Olympic land legacy. Chief Jacob represented Indigenous Peoples on the Vancouver Organizing Committee's Board of Directors for the 2010 Olympic and Paralympic Winter Games.
About Quest Water Global Inc.
Quest Water Global Inc., through its wholly-owned operating subsidiary Quest Water Solutions Inc., is an innovative water technology company that provides sustainable and environmentally sound solutions to water scarce regions. We use proven technologies to create economically viable products that address the critical shortage of clean water in water-scarce regions and developing nations. Quest’s goal is to address the vital issue of water quality and water supply by providing an alternative, sustainable source of pure water at the smallest possible environmental cost, while becoming a leading provider of decentralized, turnkey solutions using alternative energy for the production, purification, desalination, and distribution of clean, potable water. For more information, visit our website at www.QuestWaterSolutions.com.
Notice Regarding Forward Looking Statements
This press release contains projections and forward-looking statements, as that term is defined under applicable securities laws. Statements in this press release, which are not purely historical, are forward-looking statements. These statements are only predictions and involve known and unknown risks which may cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking information, including: negative results from the Company's operations; the effects of government regulation on the Company's business; risks associated with the Company's ability to obtain and protect rights to its intellectual property; risks and uncertainties associated with the Company's ability to raise additional capital; loss of management; and other factors beyond the Company's control. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, levels of activity or performance. Further, any forward-looking statement speaks only as of the date on which such statement is made, and, except as required by applicable law, the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for management to predict all such factors and to assess in advance the impact of such factors on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement. Readers should also refer to the risk factor disclosures and other disclosures outlined in the Company's periodic reports filed from time-to-time with the Securities and Exchange Commission on EDGAR at www.sec.gov and with the British Columbia Securities Commission on SEDAR at www.sedar.com.
Source: Quest Water Global, Inc.
CONTACT: John Balanko, President & CEO
Quest Water Global, Inc.
+1 888 897 5536
inquiries@questwatersolutions.com
www.questwatersolutions.com
Jacqueline McClure, Corporate Communications
Quest Water Global, Inc.
+1 604 565 1103
jmcclure@questwatersolutions.com
Logo.jpg
Source: GlobeNewswire (September 20, 2018 - 9:10 AM EDT)
News by QuoteMedia
QUEST WATER PROVIDES CORPORATE UPDATE https://on.mktw.net/2xCi0r9
$QWTR
What is $CACH underlying story to make it go back up to $0.05 (nickel)?
Why do the MM's want our shares so badly?
Thanks!
What is $CACH underlying story to make it go back up to $0.05 (nickel)?
Why do the MM's want our shares so badly?
Thanks!
CEO Letter to Shareholders September-2018
Investor Relations:
Dave Morse, CEO, (866) 726-7543
info@pocketfinder.com
Location Based Technologies, Inc. CEO Letter to Shareholders
IRVINE, Calif. September 6, 2018 Location Based Technologies® Inc. (OTCBB:LBAS) CEO, Dave Morse,
has released a letter to shareholders.
Dear Shareholders,
This is a special update focused upon the formalization and expansion of our valued relationship with
Yepzon Inc.
Both companies have entered an agreement to form a Joint Venture as a limited liability company,
registered in the State of Nevada, under the name: Tracking Solutions, LLC. The focus of this Joint
Venture is upon the Consumer personal tracking market located in the USA, Canada and Mexico. This
market primarily includes the tracking of children, elderly and pets. By combining collective knowledge,
skills, and assets the companies will achieve more and have a much greater impact on the personal
tracking markets in these targeted territories.
The jointly desired outcome is simple and two-fold: become the recognized leader/provider of personal
trackers in the US, Canada and Mexico; and, to dramatically increase the size of our personal tracker
customer base. This will be accomplished through increased sales channels providing high value to cost
and delivering the best quality and form of GPS/cellular based trackers (with full integration of other
supporting location technologies such as Wi-Fi, BLE, Cell-ID, etc.).
LBT has a long history of award winning customer service. LBT will immediately begin to provide the
same quality of customer service to all existing Yepzon USA customers as well for the new Tracking
Solutions customers. Yepzon USA will like-wise take the lead on sales and marketing functions by
leveraging in-process expansion into strategic brick-and-mortar retail stores along with its robust push
into the online markets.
Jointly, each company’s product and solution match existing market needs. The Yepzon Freedom
tracker delivers an “on demand” lower service cost solution with simplicity, elegance and style. LBT’s
Pocketfinder+ device is a full featured, time-interval based tracker that meets the needs of those
Consumers who desire a constant tracking solution – with the same elegance and style! The companies
share a rigorous customer centric approach with fanatic focus on high quality, technology leading
products and services. These values will not change.
Each member retains all rights and privileges for their respective proprietary software and intellectual
property. Each member will also be free to independently pursue Commercial/Business applications
utilizing personal or vehicle trackers.
Mr. Juha “John” Kiesi, CEO of Yepzon Inc., states: “Yepzon sees consolidating consumer tracking market
as a fundamental step in preparing for future growth. Shared marketing, distribution channels and best
practices, together with obvious synergies at back office and support functions help us reach our mutual
goals faster and maintain the technology and service lead.”
The creation of this Joint Venture fulfills our previously stated “initial M&A step” to join the Consumer
personal tracking business of PocketFinder with Yepzon Inc.’s Consumer initiatives. We seek to deliver a
win-win for existing and future customers who are looking for top quality GPS/cellular based personal
tracking solutions for family use in our combined effort to drive growth and wider acceptance of use
within the accelerating IoT market.
Sincerely,
David M. Morse, PhD
CEO
Forward Looking Statements
This letter contains certain forward-looking statements of our intentions, hopes, beliefs, expectations,
strategies, and predictions with respect to future activities or other future events or conditions within
the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act
of 1934. These statements are usually identified by the use of words such as “believe,” “will,”
“anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “should,” “could,” or similar expressions.
These statements are only predictions and involve known and unknown risks, uncertainties and other
factors. Actual results may materially different from the results, levels of activity, performance or
achievements, express or implied by these forward-looking statements.
Although we believe that the assumptions underlying the forward-looking statements contained in this
report are reasonable, any of the assumptions could be inaccurate, and, therefore, there can be no
assurance that the forward-looking statements included in this report will prove to be accurate. We will
not update these statements unless the securities laws require us to do so. Accordingly, you should not
rely on forward-looking statements because they are subject to known and unknown risks,
uncertainties, and other factors that may cause our actual results to differ materially from those
contemplated by the forward-looking statements.
https://locationbasedtech.com/wp-content/uploads/2018/09/Shareholder-letter-September-2018.pdf
$LBAS
Can you post it here?
Thanks!
Twitter_Post: @ImmuneLDN Immune Therapeutics in attendance at the 2018 United States Conference on AIDS (USCA).
Meeting times with representatives are available pre and post Plenary times.
Contact:
David Donlin
Cervelle Group
407-490-6635
http://2018usca.org/
@NMACCommunity @USCA_NMAC $IMUN
3:29 PM - 6 Sep 2018
Immune Therapeutics in attendance at the 2018 United States Conference on AIDS (USCA).
— Immune Therapeutics (@ImmuneLDN) September 6, 2018
Meeting times with representatives are available pre and post Plenary times.
Contact:
David Donlin
Cervelle Group
407-490-6635https://t.co/f3c0DzhPqm@NMACCommunity @USCA_NMAC $IMUN
INVO BIOSCIENCE $IVOB SI Increased By 2277.78%
EPS for Neogen (NEOG) Expected At $0.28;
September 7, 2018 - By Mike Johnson
INVO Bioscience, Inc. (OTCMKTS: $IVOB
Analysts expect Neogen Corporation (NASDAQ:NEOG) to report $0.28 EPS on September, 18.They anticipate $0.05 EPS change or 21.74% from last quarter’s $0.23 EPS. NEOG’s profit would be $14.51 million giving it 81.74 P/E if the $0.28 EPS is correct. After having $0.33 EPS previously, Neogen Corporation’s analysts see -15.15% EPS growth. The stock increased 0.94% or $0.85 during the last trading session, reaching $91.55. About 80,733 shares traded. Neogen Corporation (NASDAQ:NEOG) has risen 56.69% since September 7, 2017 and is uptrending. It has outperformed by 44.12% the S&P500. Some Historical NEOG News: 22/03/2018 – NEOGEN 3Q SPLIT ADJ. EPS 32C; 22/03/2018 – Neogen 3Q Rev $95.9M; 06/04/2018 – Jerome Hagedorn Named Neogen VP of Food Safety Ops; 22/03/2018 – NEOGEN CORP NEOG.O : CRAIG-HALLUM RAISES TARGET PRICE TO $65 FROM $63; RATING HOLD; 22/03/2018 – Neogen 3Q EPS 32c; 22/03/2018 – NEOGEN 3Q EPS 32C, EST. 23C; 17/05/2018 – Consolidated Research: 2018 Summary Expectations for TrueCar, Roadrunner Transportation, Eldorado Gold, Neogen, Ashford Hospita; 22/03/2018 NEOGEN 3Q REV. $95.9M, EST. $97.9M; 06/04/2018 – Hagedorn named Neogen VP of food safety operations; 20/04/2018 – DJ Neogen Corporation, Inst Holders, 1Q 2018 (NEOG)
INVO BIOSCIENCE INC (OTCMKTS:IVOB) had an increase of 2277.78% in short interest. IVOB’s SI was 85,600 shares in September as released by FINRA. Its up 2277.78% from 3,600 shares previously. With 539,200 avg volume, 0 days are for INVO BIOSCIENCE INC (OTCMKTS:IVOB)’s short sellers to cover IVOB’s short positions. The SI to INVO BIOSCIENCE INC’s float is 0.1%. The stock decreased 4.14% or $0.02 during the last trading session, reaching $0.41. About shares traded. INVO Bioscience, Inc. (OTCMKTS:IVOB) has 0.00% since September 7, 2017 and is . It has underperformed by 12.57% the S&P500.
Investors sentiment increased to 6.71 in 2018 Q1. Its up 5.22, from 1.49 in 2017Q4. It is positive, as 13 investors sold Neogen Corporation shares while 15 reduced holdings. 27 funds opened positions while 161 raised stakes. 90.94 million shares or 167.86% more from 33.95 million shares in 2017Q4 were reported. Huntington Commercial Bank owns 1,186 shares. Voya Invest Mngmt Ltd Co holds 22,314 shares or 0% of its portfolio. Thrivent Fin For Lutherans, a Minnesota-based fund reported 34,702 shares. Louisiana State Employees Retirement System reported 22,866 shares or 0.07% of all its holdings. Price T Rowe Assocs Md holds 0% or 16,029 shares. New England Private Wealth has invested 0.45% in Neogen Corporation (NASDAQ:NEOG). Raymond James And Assocs owns 4,961 shares for 0% of their portfolio. Ny State Common Retirement Fund accumulated 1.04M shares or 0.09% of the stock. Smithfield owns 46 shares or 0% of their US portfolio. The New York-based Bnp Paribas Arbitrage Sa has invested 0% in Neogen Corporation (NASDAQ:NEOG). Citadel Advisors Ltd Llc holds 206,871 shares or 0.01% of its portfolio. Millennium Mngmt holds 0% or 3,012 shares. Ny State Teachers Retirement Systems holds 52,513 shares or 0.01% of its portfolio. Cambridge Research Advsrs owns 0.02% invested in Neogen Corporation (NASDAQ:NEOG) for 28,354 shares. Creative Planning stated it has 0% of its portfolio in Neogen Corporation (NASDAQ:NEOG).
More recent Neogen Corporation (NASDAQ:NEOG) news were published by: Seekingalpha.com which released: “Neogen acquires genetic services provider for cattle breeding” on September 05, 2018. Also Streetinsider.com published the news titled: “Neogen Corp. (NEOG) to Acquire Livestock Genetic Services” on September 04, 2018. Twst.com‘s news article titled: “Derek Johnston, Portfolio Manager for Conestoga Capital, Owns Neogen (NASDAQ:NEOG), CoStar Group (NASDAQ …” with publication date: August 09, 2018 was also an interesting one.
Neogen Corporation, together with its subsidiaries, develops, makes, and markets various products for food and animal safety worldwide. The company has market cap of $4.75 billion. It operates through two divisions, Food Safety and Animal Safety. It has a 75.66 P/E ratio. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.
Neogen Corporation (NASDAQ:NEOG) Institutional Positions Chart
https://enbulletin.com/2018/09/07/eps-for-neogen-neog-expected-at-0-28-invo-bioscience-ivob-si-increased-by-2277-78/
$IVOB
Did you catch any below 0035? Which MM sold that 148k block?
Cascara and Suncare? Kokua Sun Care Hawaiian Natural Zinc Sunscreen with KonaRed® Hawaiian Coffee Fruit Extract
The same KonaRed® Hawaiian coffee fruit extract found in our Hawaiian Cascara Juice is also a superfood for the skin! Kokua Sun Care uses this bright red super fruit extract in its reef safe Hawaiian Natural Zinc Sunscreen because it is a potent source of natural antioxidants due to its extremely high concentrations of polyphenols. The extract is made from the typically discarded fruit of the Kona coffee plants grown in the rich volcanic soil of Hawaii coffee farms.
Hawaiian Cascara Juice
Scientific research shows that cascara has the highest antioxidant capacity of all botanicals – up to 10x more than other topical antioxidants. It has anti-inflammatory, anti-aging, and hydrating benefits for the skin. Not only does it neutralize free radicals, protecting the skin against DNA damage caused by the sun, but it also restores the integrity of the skin after UV exposure.
Kokua Sun Care Hawaiian Natural Zinc Sunscreen SPF 50 is antioxidant rich containing 7 Hawaiian ingredients, including the cascara, and it goes on smooth like a moisturizing lotion. It provides broad spectrum water resistant protection with 25% non-nano zinc oxide – the highest percentage on the market – as the only active ingredient to provide a natural physical barrier to the sun’s UVA and UVB rays. Kokua Sun Care never uses the coral killing chemicals oxybenzone or octinoxate that is outlawed in Hawaii or any of the other marine toxic ingredients commonly found in personal care products.
Next time you head out into the sun, grab a refreshing Hawaiian Cascara Juice and Kokua Sun Care and enjoy the potent antioxidant benefits of this superfruit on the inside and outside!
If you would like to learn more about Kokua Sun Care, visit http://www.kokuasuncare.com and use promo code KOKUA15 for a 15% discount and follow @KokuaSunCare on Instagram for more information. If you are interested in reef safe sunscreen and want to know What Reef Safe Really Means, click here.
http://bit.ly/2MV0bxR